Elevating the Quality of Care in Ulcerative Colitis--ABIM MOC Credits Available
PROGRAM DESCRIPTION The objective of this interactive on-demand, enduring Internet activity is to provide gastroenterology clinicians and others with the latest data regarding evolving treatment goals in ulcerative colitis (UC), ...
The objective of this interactive on-demand, enduring Internet activity is to provide gastroenterology clinicians and others with the latest data regarding evolving treatment goals in ulcerative colitis (UC), adoption of an individualized treatment approach to the selection, initiation, and tailoring of disease-modifying therapies for achieving and sustaining remission of UC, and elucidation of the key clinical findings and protocols established in decision support tools published for gastroenterology professionals who manage/treat patients with UC.Utilizing an expert faculty team and featuring video vignettes of actual patients, the objective of this web-based activity is to provide clinicians with a better understanding of the “hot topics” in UC arising from current clinical and research data, and pertinent guideline updates, specifically the recent collection of clinical decision support tools designed specifically for IBD care pathways by the American Gastroenterological Association (AGA). For each clinical scenario, the program moderator will invite the faculty to make a short didactic case presentation from the “hot seat.” During the case presentation, faculty will challenge the audience to make treatment decisions, focusing on patients with unmet needs in UC. At the conclusion of each case presentation, the faculty will participate in a brief roundtable discussion moderated by the Activity Chair.
Upon completion of these activities, participants should be better able to:Identify patients with moderate-to-severe ulcerative colitis (UC) who are at high risk for adverse outcomes including surgery and select appropriate treatment for these patientsDescribe reasons for non-response to UC therapy and be able to adjust treatment regimens using evidence-based algorithms and data for various treatment options to help patients attain remissionDiscuss the safety, efficacy, place in therapy, and impact on practice of biologic agents and small molecules that are currently in clinical trials for the treatment of UCAnalyze real-world data to improve the quality of care provided for UC in clinical practice, scrutinize the safety and efficacy of various treatment options, and review data to find patterns that can provide insights into clinical challenges in UC
I'm interested in this
Share with others
Write the first review
Share with others